Ozempic 1 mg (Semaglutide)
| Active Ingredient | Semaglutide |
|---|---|
| Indication: | Type 2 diabetes |
| Manufacturer: | Novo Nordisk India |
| Strength | 1mg |
| Packaging | 1 Pen & 4 Disposable Needles |
Ozempic 1 mg contains Semaglutide, a GLP-1 receptor agonist that offers powerful support for managing type 2 diabetes and promoting weight loss. It works by increasing insulin secretion, reducing glucose production in the liver, and slowing gastric emptying—all of which contribute to lower blood sugar levels and a feeling of fullness after meals.
Ozempic is administered once weekly via subcutaneous injection, making it convenient for long-term use. The 1 mg dose is often used after titrating from a lower strength, offering enhanced control for patients who need stronger glycemic management. In addition to improving HbA1c levels, Ozempic is clinically proven to reduce the risk of major cardiovascular events in people with type 2 diabetes and heart disease. Regular use, along with lifestyle modifications, helps patients achieve sustainable blood sugar control and weight reduction.








There are no reviews yet.